Changes in the availability of medications for opioid use disorder in prisons and jails in the United States during the COVID-19 pandemic

BACKGROUND: During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals. The impact of COVID-19 on the supply of MOUD in U.S. prisons and jails is not known. METHODS: We used cross-sectional national monthly data from the IQVIA...

Descripción completa

Detalles Bibliográficos
Autores principales: Dadiomov, David, Trotzky-Sirr, Rebecca, Shooshtari, Andrew, Qato, Dima M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750914/
https://www.ncbi.nlm.nih.gov/pubmed/35033953
http://dx.doi.org/10.1016/j.drugalcdep.2022.109291

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8750914/
https://www.ncbi.nlm.nih.gov/pubmed/35033953
http://dx.doi.org/10.1016/j.drugalcdep.2022.109291

Ejemplares similares